Harvard Bioscience, Inc.

HBIO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,108$4,283$4,508$7,821
Short-Term Investments$0$0$0$0
Receivables$14,866$16,099$16,705$21,834
Inventory$23,245$24,716$26,439$27,587
Other Curr. Assets$2,898$3,940$3,472$4,341
Total Curr. Assets$45,117$49,038$51,124$61,583
Property Plant & Equip (Net)$11,238$8,754$9,182$10,312
Goodwill$56,324$57,065$56,260$57,689
Intangibles$11,132$16,036$21,014$27,385
Long-Term Investments$0$3,500$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,833$2,973$7,780$5,375
Total NC Assets$81,527$88,328$94,236$100,761
Other Assets$0$0$0$0
Total Assets$126,644$137,366$145,360$162,344
Liabilities
Payables$4,787$5,554$6,447$4,911
Short-Term Debt$38,114$7,275$5,946$5,377
Tax Payable$0$0$0$224
Deferred Revenue$3,806$0$3,370$4,266
Other Curr. Liab.$8,251$13,713$7,486$10,538
Total Curr. Liab.$54,958$26,542$23,249$25,316
LT Debt$6,381$35,498$48,295$51,583
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$710$776$590$1,558
Other NC Liab.$1,255$1,476$1,006$486
Total NC Liab.$8,346$37,750$49,891$53,627
Other Liabilities$0$0$0$0
Cap. Leases$7,539$6,210$7,417$8,630
Total Liabilities$63,304$64,292$73,140$78,943
Equity
Pref Stock$0$0$0$0
Common Stock$441$434$454$452
Retained Earnings-$158,010-$145,605-$142,190-$132,674
AOCI-$15,670-$14,190-$15,052-$10,027
Other Equity$236,579$232,435$229,008$225,650
Total Equity$63,340$73,074$72,220$83,401
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$126,644$137,366$145,360$162,344
Net Debt$40,387$38,490$49,733$49,139